• About Us
    • Careers
  • M&A Services
    • Buy Side Advisory
    • Capital Raising
    • Sell Side Advisory
    • Transaction Planning & Readiness Review
  • Industry Expertise
    • Business Services & Technology
    • Consumer, Food & Retail
    • Healthcare
    • Industrials
    • Plastics & Packaging
  • Transactions
  • Team
  • News & Insights
    • Events
    • Industry Updates
    • News
    • Perspectives
Menu
  • About Us
    • Careers
  • M&A Services
    • Buy Side Advisory
    • Capital Raising
    • Sell Side Advisory
    • Transaction Planning & Readiness Review
  • Industry Expertise
    • Business Services & Technology
    • Consumer, Food & Retail
    • Healthcare
    • Industrials
    • Plastics & Packaging
  • Transactions
  • Team
  • News & Insights
    • Events
    • Industry Updates
    • News
    • Perspectives
Contact
  • Back to Team

Bryan Hughes

Managing Director

Healthcare

  • bryan.hughes@pmcf.com
  • Vcard
248.223.3678
  • LinkedIn

Mr. Hughes is a Managing Director of P&M Corporate Finance and leads the firm’s Medical Technology team. He has over 10 years of business and transaction advisory experience, specializing in assisting clients with mergers and acquisitions, leveraged buyouts, private placements, financings, valuation and strategic consulting. Bryan’s clients have ranged from global life sciences companies to small, privately held businesses. In addition to leading the firm’s Medical Technology team, he has also completed transactions in business services, consumer and industrial sectors.

Mr. Hughes earned a B.B.A. with emphasis in finance from the Stephen M. Ross School of Business at the University of Michigan. He is a licensed securities representative, holding Series 7 and 63 registrations. He has written numerous articles and is a frequent speaker on healthcare investment banking topics.

Transactions

has been acquired by

has been acquired by

a portfolio company of

a portfolio company of

has been acquired by

has been acquired by

a portfolio company of

a business unit of

has been acquired by

a portfolio company of

has acquired certain assets of

has sold

to

have been acquired by

has been acquired by

has acquired

has acquired

completed the private placement of $30,500,000 convertible preferred equity with Pharos Capital Group, LLC, Highlander Partners, LP, Hopewell Ventures, and River Cities Capital Funds

has divested its

implant product line to

a Healthpoint Capital Company

has acquired microneedle technology from

has licensed its corplex technology for certain applications to

has acquired a majority equity interest in

has acquired the medical product business of

and

have been acquired by

has sold an equity interest to

has acquired

Previous
Next

Featured Articles

Why 2021 RAP Changes Will Lead to a Challenging Year for Home Health Agencies, and How Businesses Can Prepare
  • January 20, 2021
  • | Perspectives
  • | Healthcare, Healthcare Services
Medical Technology M&A Pulse – Q3 2020
  • November 23, 2020
  • | Industry Updates
  • | Healthcare, Medical Technology
Medical Technology M&A Pulse – Q1 2020
  • June 9, 2020
  • | Industry Updates
  • | Healthcare, Medical Technology
Bryan Hughes Promoted to Managing Director
  • February 5, 2020
  • | News
  • | Healthcare
Contact

Follow Us On

Securities offered through P&M Corporate Finance, LLC. Member of FINRA and SIPC.

blank
Cfi Logo White 94x94 On About

Home

  • About
  • Team
  • Careers

M&A Services

  • Buy Side Advisory
  • Capital Raising
  • Sell Side Advisory
  • Transaction Planning & Readiness Review

Industry Expertise

  • Business Services & Technology
  • Consumer, Food & Retail
  • Healthcare
  • Industrials
  • Plastics & Packaging

News & Insights

  • Transactions
  • News
  • Industry Updates
  • Perspectives
  • Events

©2021 PMCF

  • Member SIPC​
  • Member FINRA
  • FINRA Broker Check
  • Business Continuity Plan​
  • Disclaimer​
  • Privacy Policy​
Cookie Notice: This site uses cookies to provide you with a more responsive and personalized service. By using this site you agree to our use of cookies. Please read our Privacy Policy for more information on the cookies we use.AgreePrivacy policy